Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +0.31% | +12.46% | +83.62% |
14/05 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
14/05 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.62% | 61Cr | |
+54.05% | 6.39TCr | |
-2.02% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.87TCr | |
+2.89% | 1.27TCr | |
+22.40% | 1.21TCr | |
+27.49% | 1.21TCr |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Earnings Flash (TSHA) TAYSHA GENE THERAPIES Reports Q1 Revenue $3.4M, vs. Street Est of $2.6M